United States · FDA National Drug Code directory
Buspirone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42543-743_243ca572-833a-4f08-9c96-dc75370fda33
- Product NDC
- 42543-743
- Form
- TABLET
- Composition / generic term
- Buspirone Hydrochloride
- Labeler
- Strides Pharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210401
- Source listing expiry
- 20271231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (42543-743-03) · 42543-743-03
- 100 TABLET in 1 BOTTLE (42543-743-06) · 42543-743-06
- 180 TABLET in 1 BOTTLE (42543-743-18) · 42543-743-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →